Analytical Data
-
Gene name
NtnG2
- Application
-
Alternative Names
NtnG2；KIAA1857；LMNT2；Netrin-G2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96CW9
-
Expression Region
18-507aa
-
AA Sequence
DYD ICKSWVTTDE GPTWEFYACQ PKVMRLKDYV KVKVEPSGIT CGDPPERFCS HENPYLCSNE CDASNPDLAH PPRLMFDKEE EGLATYWQSI TWSRYPSPLE ANITLSWNKT VELTDDVVMT FEYGRPTVMV LEKSLDNGRT WQPYQFYAED CMEAFGMSAR RARDMSSSSA HRVLCTEEYS RWAGSKKEKH VRFEVRDRFA IFAGPDLRNM DNLYTRLESA KGLKEFFTLT DLRMRLLRPA LGGTYVQREN LYKYFYAISN IEVIGRCKCN LHANLCSMRE GSLQCECEHN TTGPDCGKCK KNFRTRSWRA GSYLPLPHGS PNACATAGSF GNCECYGHSN RCSYIDFLNV VTCVSCKHNT RGQHCQHCRL GYYRNGSAEL DDENVCIECN CNQIGSVHDR CNETGFCECR EGAAGPKCDD CLPTHYWRQG CYPNVCDDDQ LLCQNGGTCL QNQRCACPRG YTGVRCEQPR CDPADDDGGL DCDRAPG
-
Molecular Weight
59.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NtnG2, or N-terminal propeptide of the human protein NtnG2, represents a class of proteins that are gaining interest due to their potential biological and therapeutic functions. This protein is part of the Ntn hydrolase family, characterized by a unique N-terminal cleavage that activates its enzymatic activity. Research into NtnG2 has been spurred by its implications in various biological processes, including neuroprotection, metabolic regulation, and cell signaling. Studies have shown that NtnG2 may play a role in modulating the immune response and influencing cell survival, making it a candidate for investigations into diseases such as neurodegenerative disorders and cancer. Moreover, understanding the structure-function relationship of NtnG2 could lead to the development of novel therapeutic strategies. As recombinant protein technology advances, the production and analysis of NtnG2 in various systems have facilitated deeper insights into its function and interactions. This growing body of research underscores the significance of NtnG2 in cell biology and its potential as a target for drug discovery and development, raising hopes for innovations in treating complex diseases. As the scientific community continues to unravel the mechanisms underlying NtnG2 activities, it is becoming increasingly clear that this protein may offer valuable insights into the intersection of metabolism, immunity, and neuronal health. The ongoing studies aim to elucidate its precise roles and how it can be harnessed in clinical applications. Overall, the investigation of NtnG2 not only enhances our understanding of fundamental biological processes but also opens avenues for novel therapeutic interventions.
